Multiple Sclerosis Treatment and Melanoma Development

Therapy of multiple sclerosis (MS) with disease-modifying agents such as natalizumab or fingolimod has been associated with the development of cutaneous melanoma. Here we briefly revise literature data and report of a case of a 48-year old woman who developed a melanoma and several atypical naevi af...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbone, Maria Luigia, Lacal, Pedro Miguel, Messinese, Serena, De Giglio, Laura, Pozzilli, Carlo, Persechino, Severino, Mazzanti, Cinzia, Failla, Cristina Maria, Pagnanelli, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216218/
https://www.ncbi.nlm.nih.gov/pubmed/32331328
http://dx.doi.org/10.3390/ijms21082950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216218/
https://www.ncbi.nlm.nih.gov/pubmed/32331328
http://dx.doi.org/10.3390/ijms21082950

Ejemplares similares